2015

1. Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

   Current Medical Research and Opinion, Vol. 31, Núm. 6, pp. 1129-1137